Frontiers in Pharmacology (Mar 2023)

Therapeutic implications of current Janus kinase inhibitors as anti-COVID agents: A review

  • Nem Kumar Jain,
  • Nem Kumar Jain,
  • Mukul Tailang,
  • Hemant Kumar Jain,
  • Balakumar Chandrasekaran,
  • Biswa Mohan Sahoo,
  • Anandhalakshmi Subramanian,
  • Neelaveni Thangavel,
  • Afaf Aldahish,
  • Kumarappan Chidambaram,
  • M. Alagusundaram,
  • Santosh Kumar,
  • Palani Selvam

DOI
https://doi.org/10.3389/fphar.2023.1135145
Journal volume & issue
Vol. 14

Abstract

Read online

Severe cases of COVID-19 are characterized by hyperinflammation induced by cytokine storm, ARDS leading to multiorgan failure and death. JAK-STAT signaling has been implicated in immunopathogenesis of COVID-19 infection under different stages such as viral entry, escaping innate immunity, replication, and subsequent inflammatory processes. Prompted by this fact and prior utilization as an immunomodulatory agent for several autoimmune, allergic, and inflammatory conditions, Jakinibs have been recognized as validated small molecules targeting the rapid release of proinflammatory cytokines, primarily IL-6, and GM-CSF. Various clinical trials are under investigation to evaluate Jakinibs as potential candidates for treating COVID-19. Till date, there is only one small molecule Jakinib known as baricitinib has received FDA-approval as a standalone immunomodulatory agent in treating critical COVID-19 patients. Though various meta-analyses have confirmed and validated the safety and efficacy of Jakinibs, further studies are required to understand the elaborated pathogenesis of COVID-19, duration of Jakinib treatment, and assess the combination therapeutic strategies. In this review, we highlighted JAK-STAT signalling in the pathogenesis of COVID-19 and clinically approved Jakinibs. Moreover, this review described substantially the promising use of Jakinibs and discussed their limitations in the context of COVID-19 therapy. Hence, this review article provides a concise, yet significant insight into the therapeutic implications of Jakinibs as potential anti-COVID agents which opens up a new horizon in the treatment of COVID-19, effectively.

Keywords